Moderna mRNA flu vaccine bests standard shot in peer-reviewed trial, FDA decision due in August
dlvr.it/TSRjyR
Story Details
| Last Updated | |
| Total Articles | 3 |
Main Topics
research involving fundamental scientific principles that may apply to a preclinical understanding – to clinical research, which involves studies of people who may be subjects in clinical trials
News on this topic
Moderna mRNA flu vaccine beats standard shot in phase 3 trial: Results published in the New England Journal of Medicine show the mRNA shot reduced flu illness by ...
dlvr.it/TSSPrD
Similar to This
Previous
Moderna falls ahead of cancer vaccine data next week: Moderna (MRNA) stock sinks as investors await an Oct. 24 presentation containing additional Phase 3 data ...
seekingalpha.com/news/4653908-moderna-falls-ahead-of-cancer-vaccine-data-next-week
Flu season is already here. Here’s what to know about this year’s flu shots.: This year’s flu season has arrived about seven weeks earlier than in 2025 or 2024.
marketwatch.com/story/flu-season-is-already-here-heres-what-to-know-about-this-years-flu-shots-58aeb705
Paid articlePaywall
‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial: The drug is based on the same messenger RNA (mRNA) technology behind Covid-19 vaccines ...
straitstimes.com/world/united-states/breakthrough-mrna-cancer-drug-curbs-melanoma-in-large-trial
Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test
bnnbloomberg.ca/business/company-news/2026/08/19/moderna-shares-surge-after-it-says-its-experimental-mrna-cancer-treatment-passed-a-key-test/
STAT Aug 06
Covid can reactivate dormant viruses, according to study: A CDC director officially confirmed, Moderna's mRNA flu shot approved, and other health news from ...
statnews.com/2026/08/06/health-news-covid-can-reactivate-dormant-viruses-study-finds/
STAT Aug 06
Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
statnews.com/pharmalot/2026/08/06/moderna-flu-shot-gene-editing-trial-death-pharmalittle-newsletter/
Paid articlePaywall
U.S. FDA panel considers a first-of-its-kind flu vaccine using mRNA technology: U.S. health advisers are debating a new kind of flu vaccine Thursday ...
ctvnews.ca/health/article/us-fda-panel-considers-a-first-of-its-kind-flu-vaccine-using-mrna-technology/
Moderna's mRNA flu vaccine backed by FDA advisors: Advisers to the US Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine ...
reuters.com/legal/litigation/modernas-mrna-flu-vaccine-faces-fda-advisory-panel-scrutiny-2026-06-18/
Moderna Surges On This Surprising FDA View For Its mRNA-Based Flu Shot: Moderna stock surged Tuesday after documents posted ahead of a key meeting suggested the ...
investors.com/news/technology/moderna-stock-fda-briefing-documents-flu-shot/
Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine: Amid RFK Jr.'s anti-vaccine agenda, Moderna withdrew its FDA application last year.
arstechnica.com/health/2026/04/europe-not-us-first-to-authorize-modernas-combo-mrna-flu-covid-vaccine/
Under Trump, mRNA Skepticism Threatens a Promising Technology: The administration had cut crucial funding for mRNA-based therapies. The rest of the world might ...
undark.org/2026/03/09/trump-mrna-skepticism/
FDA reverses course, will review Moderna's mRNA flu vaccine: Moderna said the FDA has agreed to review its mRNA flu vaccine, reversing an earlier decision to ...
nbcnews.com/health/health-news/fda-reverses-course-will-review-modernas-mrna-flu-vaccine-rcna259531
Key FactsFDA Reverses Course on Moderna’s mRNA Flu Vaccine
Feb 18, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: cnbc.com
Summary created with AI assistance · Source: cnbc.com
- The FDA agreed to review Moderna’s previously rejected application for its mRNA flu vaccine.
- Moderna seeks full approval for adults aged 50-64 and accelerated approval for those 65 and older.
- An additional post-marketing study in older adults is required following approval.
- The reversal came after a productive FDA meeting and a revised trial design addressing regulatory concerns.
We're hopeful and optimistic about the platform but would also like to see the data.— FDA Commissioner Dr. Marty Makary expressed his views on mRNA technology in the context of vaccine development.
Trump minister Kennedy cuts large sums for certain vaccines: US Secretary of Health and Human Services Robert F. Kennedy Jr. is a vaccination sceptic ...
fr.de/politik/trump-minister-kennedy-streicht-hohe-summen-fuer-bestimmte-impfstoffe-zr-93870850.html
Moderna says mRNA flu vaccine sailed through trial, beating standard shot: Moderna hailed the results, but the shot’s future under RFK Jr. is murky.
arstechnica.com/health/2025/07/moderna-says-its-mrna-seasonal-flu-shot-is-27-better-than-current-vaccine/
Key FactsModerna’s Flu Vaccine Surpasses Traditional Shot Effectiveness
Jun 30, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: theglobeandmail.com
Summary created with AI assistance · Source: theglobeandmail.com
- Moderna’s experimental mRNA-1010 flu vaccine proved 26.6% more effective than GSK’s approved shot in adults aged 50 and older.
- In adults 65 and above, the vaccine’s efficacy was 27.4% higher, targeting the group most at risk for severe flu.
- Previous trials demonstrated the vaccine induced a stronger immune response against all four influenza A and B strains.
- Plans include regulatory engagement to advance approval, leveraging the vaccine’s potential for rapid adaptation to future flu pandemics.
The severity of this past flu season underscores the need for more effective vaccines.— CEO Stéphane Bancel commented on the results of the study regarding the new vaccine.
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
pressdemocrat.com/article/news/moderna-study-shows-immune-response-in-older-adults-for-a-combo-flu-and-cov/
Key FactsModerna Combines Flu and COVID-19 Vaccines
May 7, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: apnews.com
Summary created with AI assistance · Source: apnews.com
- A new combination flu and COVID-19 vaccine showed stronger immune responses in individuals over 50 compared to existing standalone shots, according to a Moderna study.
- Side effects reported included injection site pain, fatigue, and headaches.
- The FDA is requesting additional data on the vaccine's effectiveness before granting approval.
- Experts express doubts about the popularity and effectiveness of the combination vaccine in managing seasonal flu outbreaks.
I agree in this case with FDA that efficacy data are important to see.— Dr. Greg Poland, a vaccine researcher at Mayo Clinic, comments on the importance of efficacy data for the new combo vaccine.
Next